Satellos Bioscience Inc.
MSCLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,821 | -$5,608 | -$6,141 | -$6,106 |
| Dep. & Amort. | $3 | $0 | $1 | $12 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $774 | $834 | $642 | $447 |
| Change in WC | $803 | $319 | -$1,865 | -$988 |
| Other Non-Cash | $194 | -$388 | -$3 | -$1,173 |
| Operating Cash Flow | -$4,126 | -$4,843 | -$7,366 | -$7,808 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$3 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15,329 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $8,475 | $0 | $25,716 |
| Other Inv. Act. | -$127 | $0 | $0 | -$37,336 |
| Investing Cash Flow | -$15,459 | $8,472 | $0 | -$11,620 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $692 | $1,441 | $0 | $42,802 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$49 | $2 | $10,446 |
| Financing Cash Flow | $692 | $1,392 | $2 | $53,248 |
| Forex Effect | -$203 | $484 | $3 | $417 |
| Net Chg. in Cash | -$19,017 | $5,505 | -$7,361 | $34,237 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38,217 | $32,712 | $40,073 | $23,422 |
| End Cash | $19,304 | $38,217 | $32,712 | $57,659 |
| Free Cash Flow | -$4,129 | -$4,846 | -$7,366 | -$7,808 |